Dermatologic manifestations of antimicrobial adverse reactions with special emphasis on topical exposure.
Topical application of antimicrobial agents can lead to an increased risk of systemic reactions. Adverse reactions can occur with topical antifungals and antiviral agents in addition to antibiotics.
Rietschel
R L
RL
Ochsner Medical Institutions, New Orleans, Louisiana.
D000287:Administration, Topical; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D000935:Antifungal Agents / Q000009:adverse effects; D002701:Chloramphenicol / Q000009:adverse effects; D002981:Clindamycin / Q000009:adverse effects; D003877:Dermatitis, Contact / Q000209:etiology*; D004917:Erythromycin / Q000009:adverse effects; D006801:Humans; D008034:Lincomycin / Q000009:adverse effects; D009355:Neomycin / Q000009:adverse effects; D010406:Penicillins / Q000009:adverse effects; D012307:Risk Factors; D013424:Sulfanilamides / Q000009:adverse effects; D013752:Tetracycline / Q000009:adverse effects
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D010406:Penicillins; D013424:Sulfanilamides; D002981:Clindamycin; D004917:Erythromycin; D002701:Chloramphenicol; D008034:Lincomycin; D013752:Tetracycline; D009355:Neomycin